Filing Details

Accession Number:
0001161697-22-000457
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-15 17:01:35
Reporting Period:
2022-09-13
Accepted Time:
2022-09-15 17:01:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1369568 Catalyst Pharmaceuticals Inc. CPRX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
929985 J Patrick Mcenany 355 Alhambra Circle, Suite 801
Coral Gables FL 33134
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Disposition 2022-09-13 80,765 $15.33 4,849,452 No 4 S Direct
Common Stock, Par Value $0.001 Per Share Disposition 2022-09-14 946,846 $15.41 3,902,606 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Shares were sold for personal reasons. Shares were not sold as a result of any disagreement with the Company and Mr. McEnany remains a director and an officer of the Company.
  2. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.30 to $15.385 per share.
  3. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.25 to $15.71 per share.